English
简体中文
Total: £ 56.28
Published Date: 2025-03-25 | Pages: 107 | Tables: 105 | Pharma & Healthcare
The global market for Nocturia was valued at US$ 2849 million in the year 2024 and is projected to reach a revised size of US$ 4204 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:
1. Growing Aging Population
Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.
Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.
2. Advancements in Treatment Options
Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.
Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.
Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.
3. Increasing Awareness and Diagnosis
Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.
Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.
4. Regional Growth
North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.
Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.
Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by Type, by Sale Channels, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channels, and by regions.
Market Segmentation
By Company
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Novartis
Johnson & Johnson
Merck
Astra Zeneca
Bristol-Myers Squibb
Hainan Zhonghe Pharmaceutical
Fosun Pharma
Hybio Pharmaceutical
Rechon Life Science AB
Zhejiang Conba Pharmaceutical
Chengdu Leer Pharmaceutical
Nanjing Xingyin Pharmaceutical Group
Sun Pharmaceutical Industries Ltd.
APOTEX INC
Sagent Pharmaceuticals
Segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nocturia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Desmopressin
1.2.3 Anticholinergic Drugs
1.2.4 Alpha Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Sale Channels
1.3.1 Global Nocturia Market Growth by Sale Channels: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nocturia Market Perspective (2020-2031)
2.2 Global Nocturia Growth Trends by Region
2.2.1 Global Nocturia Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nocturia Historic Market Size by Region (2020-2025)
2.2.3 Nocturia Forecasted Market Size by Region (2026-2031)
2.3 Nocturia Market Dynamics
2.3.1 Nocturia Industry Trends
2.3.2 Nocturia Market Drivers
2.3.3 Nocturia Market Challenges
2.3.4 Nocturia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturia Players by Revenue
3.1.1 Global Top Nocturia Players by Revenue (2020-2025)
3.1.2 Global Nocturia Revenue Market Share by Players (2020-2025)
3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nocturia Revenue
3.4 Global Nocturia Market Concentration Ratio
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2024
3.5 Global Key Players of Nocturia Head office and Area Served
3.6 Global Key Players of Nocturia, Product and Application
3.7 Global Key Players of Nocturia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturia Breakdown Data by Type
4.1 Global Nocturia Historic Market Size by Type (2020-2025)
4.2 Global Nocturia Forecasted Market Size by Type (2026-2031)
5 Nocturia Breakdown Data by Sale Channels
5.1 Global Nocturia Historic Market Size by Sale Channels (2020-2025)
5.2 Global Nocturia Forecasted Market Size by Sale Channels (2026-2031)
6 North America
6.1 North America Nocturia Market Size (2020-2031)
6.2 North America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nocturia Market Size by Country (2020-2025)
6.4 North America Nocturia Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nocturia Market Size (2020-2031)
7.2 Europe Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nocturia Market Size by Country (2020-2025)
7.4 Europe Nocturia Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nocturia Market Size (2020-2031)
8.2 Asia-Pacific Nocturia Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nocturia Market Size by Region (2020-2025)
8.4 Asia-Pacific Nocturia Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nocturia Market Size (2020-2031)
9.2 Latin America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nocturia Market Size by Country (2020-2025)
9.4 Latin America Nocturia Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturia Market Size (2020-2031)
10.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nocturia Market Size by Country (2020-2025)
10.4 Middle East & Africa Nocturia Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Nocturia Introduction
11.1.4 Astellas Pharma Revenue in Nocturia Business (2020-2025)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Nocturia Introduction
11.2.4 Allergan Revenue in Nocturia Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Details
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Nocturia Introduction
11.4.4 Eli Lilly Revenue in Nocturia Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nocturia Introduction
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2020-2025)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Nocturia Introduction
11.6.4 Sanofi Revenue in Nocturia Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nocturia Introduction
11.7.4 Pfizer Revenue in Nocturia Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Nocturia Introduction
11.8.4 Abbott Revenue in Nocturia Business (2020-2025)
11.8.5 Abbott Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Nocturia Introduction
11.9.4 Teva Revenue in Nocturia Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Nocturia Introduction
11.10.4 Mylan Revenue in Nocturia Business (2020-2025)
11.10.5 Mylan Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Nocturia Introduction
11.11.4 Novartis Revenue in Nocturia Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Nocturia Introduction
11.12.4 Johnson & Johnson Revenue in Nocturia Business (2020-2025)
11.12.5 Johnson & Johnson Recent Development
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Nocturia Introduction
11.13.4 Merck Revenue in Nocturia Business (2020-2025)
11.13.5 Merck Recent Development
11.14 Astra Zeneca
11.14.1 Astra Zeneca Company Details
11.14.2 Astra Zeneca Business Overview
11.14.3 Astra Zeneca Nocturia Introduction
11.14.4 Astra Zeneca Revenue in Nocturia Business (2020-2025)
11.14.5 Astra Zeneca Recent Development
11.15 Bristol-Myers Squibb
11.15.1 Bristol-Myers Squibb Company Details
11.15.2 Bristol-Myers Squibb Business Overview
11.15.3 Bristol-Myers Squibb Nocturia Introduction
11.15.4 Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025)
11.15.5 Bristol-Myers Squibb Recent Development
11.16 Hainan Zhonghe Pharmaceutical
11.16.1 Hainan Zhonghe Pharmaceutical Company Details
11.16.2 Hainan Zhonghe Pharmaceutical Business Overview
11.16.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
11.16.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.16.5 Hainan Zhonghe Pharmaceutical Recent Development
11.17 Fosun Pharma
11.17.1 Fosun Pharma Company Details
11.17.2 Fosun Pharma Business Overview
11.17.3 Fosun Pharma Nocturia Introduction
11.17.4 Fosun Pharma Revenue in Nocturia Business (2020-2025)
11.17.5 Fosun Pharma Recent Development
11.18 Hybio Pharmaceutical
11.18.1 Hybio Pharmaceutical Company Details
11.18.2 Hybio Pharmaceutical Business Overview
11.18.3 Hybio Pharmaceutical Nocturia Introduction
11.18.4 Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.18.5 Hybio Pharmaceutical Recent Development
11.19 Rechon Life Science AB
11.19.1 Rechon Life Science AB Company Details
11.19.2 Rechon Life Science AB Business Overview
11.19.3 Rechon Life Science AB Nocturia Introduction
11.19.4 Rechon Life Science AB Revenue in Nocturia Business (2020-2025)
11.19.5 Rechon Life Science AB Recent Development
11.20 Zhejiang Conba Pharmaceutical
11.20.1 Zhejiang Conba Pharmaceutical Company Details
11.20.2 Zhejiang Conba Pharmaceutical Business Overview
11.20.3 Zhejiang Conba Pharmaceutical Nocturia Introduction
11.20.4 Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.20.5 Zhejiang Conba Pharmaceutical Recent Development
11.21 Chengdu Leer Pharmaceutical
11.21.1 Chengdu Leer Pharmaceutical Company Details
11.21.2 Chengdu Leer Pharmaceutical Business Overview
11.21.3 Chengdu Leer Pharmaceutical Nocturia Introduction
11.21.4 Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025)
11.21.5 Chengdu Leer Pharmaceutical Recent Development
11.22 Nanjing Xingyin Pharmaceutical Group
11.22.1 Nanjing Xingyin Pharmaceutical Group Company Details
11.22.2 Nanjing Xingyin Pharmaceutical Group Business Overview
11.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Introduction
11.22.4 Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025)
11.22.5 Nanjing Xingyin Pharmaceutical Group Recent Development
11.23 Sun Pharmaceutical Industries Ltd.
11.23.1 Sun Pharmaceutical Industries Ltd. Company Details
11.23.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Introduction
11.23.4 Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025)
11.23.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.24 APOTEX INC
11.24.1 APOTEX INC Company Details
11.24.2 APOTEX INC Business Overview
11.24.3 APOTEX INC Nocturia Introduction
11.24.4 APOTEX INC Revenue in Nocturia Business (2020-2025)
11.24.5 APOTEX INC Recent Development
11.25 Sagent Pharmaceuticals
11.25.1 Sagent Pharmaceuticals Company Details
11.25.2 Sagent Pharmaceuticals Business Overview
11.25.3 Sagent Pharmaceuticals Nocturia Introduction
11.25.4 Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025)
11.25.5 Sagent Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Desmopressin
Table 3. Key Players of Anticholinergic Drugs
Table 4. Key Players of Alpha Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Nocturia Market Size Growth by Sale Channels (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nocturia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nocturia Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Nocturia Market Share by Region (2020-2025)
Table 11. Global Nocturia Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Nocturia Market Share by Region (2026-2031)
Table 13. Nocturia Market Trends
Table 14. Nocturia Market Drivers
Table 15. Nocturia Market Challenges
Table 16. Nocturia Market Restraints
Table 17. Global Nocturia Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Nocturia Market Share by Players (2020-2025)
Table 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2024)
Table 20. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Nocturia, Headquarters and Area Served
Table 23. Global Key Players of Nocturia, Product and Application
Table 24. Global Key Players of Nocturia, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nocturia Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Nocturia Revenue Market Share by Type (2020-2025)
Table 28. Global Nocturia Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Nocturia Revenue Market Share by Type (2026-2031)
Table 30. Global Nocturia Market Size by Sale Channels (2020-2025) & (US$ Million)
Table 31. Global Nocturia Revenue Market Share by Sale Channels (2020-2025)
Table 32. Global Nocturia Forecasted Market Size by Sale Channels (2026-2031) & (US$ Million)
Table 33. Global Nocturia Revenue Market Share by Sale Channels (2026-2031)
Table 34. North America Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Nocturia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Nocturia Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Nocturia Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Nocturia Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Nocturia Market Size by Country (2026-2031) & (US$ Million)
Table 49. Astellas Pharma Company Details
Table 50. Astellas Pharma Business Overview
Table 51. Astellas Pharma Nocturia Product
Table 52. Astellas Pharma Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 53. Astellas Pharma Recent Development
Table 54. Allergan Company Details
Table 55. Allergan Business Overview
Table 56. Allergan Nocturia Product
Table 57. Allergan Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Ferring Pharmaceuticals Company Details
Table 60. Ferring Pharmaceuticals Business Overview
Table 61. Ferring Pharmaceuticals Nocturia Product
Table 62. Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 63. Ferring Pharmaceuticals Recent Development
Table 64. Eli Lilly Company Details
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Nocturia Product
Table 67. Eli Lilly Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Nocturia Product
Table 72. GlaxoSmithKline Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Nocturia Product
Table 77. Sanofi Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Nocturia Product
Table 82. Pfizer Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Nocturia Product
Table 87. Abbott Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Nocturia Product
Table 92. Teva Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 93. Teva Recent Development
Table 94. Mylan Company Details
Table 95. Mylan Business Overview
Table 96. Mylan Nocturia Product
Table 97. Mylan Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 98. Mylan Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Nocturia Product
Table 102. Novartis Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 103. Novartis Recent Development
Table 104. Johnson & Johnson Company Details
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Nocturia Product
Table 107. Johnson & Johnson Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 108. Johnson & Johnson Recent Development
Table 109. Merck Company Details
Table 110. Merck Business Overview
Table 111. Merck Nocturia Product
Table 112. Merck Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 113. Merck Recent Development
Table 114. Astra Zeneca Company Details
Table 115. Astra Zeneca Business Overview
Table 116. Astra Zeneca Nocturia Product
Table 117. Astra Zeneca Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 118. Astra Zeneca Recent Development
Table 119. Bristol-Myers Squibb Company Details
Table 120. Bristol-Myers Squibb Business Overview
Table 121. Bristol-Myers Squibb Nocturia Product
Table 122. Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 123. Bristol-Myers Squibb Recent Development
Table 124. Hainan Zhonghe Pharmaceutical Company Details
Table 125. Hainan Zhonghe Pharmaceutical Business Overview
Table 126. Hainan Zhonghe Pharmaceutical Nocturia Product
Table 127. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 128. Hainan Zhonghe Pharmaceutical Recent Development
Table 129. Fosun Pharma Company Details
Table 130. Fosun Pharma Business Overview
Table 131. Fosun Pharma Nocturia Product
Table 132. Fosun Pharma Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 133. Fosun Pharma Recent Development
Table 134. Hybio Pharmaceutical Company Details
Table 135. Hybio Pharmaceutical Business Overview
Table 136. Hybio Pharmaceutical Nocturia Product
Table 137. Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 138. Hybio Pharmaceutical Recent Development
Table 139. Rechon Life Science AB Company Details
Table 140. Rechon Life Science AB Business Overview
Table 141. Rechon Life Science AB Nocturia Product
Table 142. Rechon Life Science AB Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 143. Rechon Life Science AB Recent Development
Table 144. Zhejiang Conba Pharmaceutical Company Details
Table 145. Zhejiang Conba Pharmaceutical Business Overview
Table 146. Zhejiang Conba Pharmaceutical Nocturia Product
Table 147. Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 148. Zhejiang Conba Pharmaceutical Recent Development
Table 149. Chengdu Leer Pharmaceutical Company Details
Table 150. Chengdu Leer Pharmaceutical Business Overview
Table 151. Chengdu Leer Pharmaceutical Nocturia Product
Table 152. Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 153. Chengdu Leer Pharmaceutical Recent Development
Table 154. Nanjing Xingyin Pharmaceutical Group Company Details
Table 155. Nanjing Xingyin Pharmaceutical Group Business Overview
Table 156. Nanjing Xingyin Pharmaceutical Group Nocturia Product
Table 157. Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 158. Nanjing Xingyin Pharmaceutical Group Recent Development
Table 159. Sun Pharmaceutical Industries Ltd. Company Details
Table 160. Sun Pharmaceutical Industries Ltd. Business Overview
Table 161. Sun Pharmaceutical Industries Ltd. Nocturia Product
Table 162. Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 163. Sun Pharmaceutical Industries Ltd. Recent Development
Table 164. APOTEX INC Company Details
Table 165. APOTEX INC Business Overview
Table 166. APOTEX INC Nocturia Product
Table 167. APOTEX INC Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 168. APOTEX INC Recent Development
Table 169. Sagent Pharmaceuticals Company Details
Table 170. Sagent Pharmaceuticals Business Overview
Table 171. Sagent Pharmaceuticals Nocturia Product
Table 172. Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025) & (US$ Million)
Table 173. Sagent Pharmaceuticals Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
Table 177. Authors List of This Report
List of Figures
Figure 1. Nocturia Picture
Figure 2. Global Nocturia Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nocturia Market Share by Type: 2024 VS 2031
Figure 4. Desmopressin Features
Figure 5. Anticholinergic Drugs Features
Figure 6. Alpha Blockers Features
Figure 7. Diuretics Features
Figure 8. Others Features
Figure 9. Global Nocturia Market Size by Sale Channels (2020-2031) & (US$ Million)
Figure 10. Global Nocturia Market Share by Sale Channels: 2024 VS 2031
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Nocturia Report Years Considered
Figure 15. Global Nocturia Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nocturia Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nocturia Market Share by Region: 2024 VS 2031
Figure 18. Global Nocturia Market Share by Players in 2024
Figure 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2024
Figure 21. North America Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nocturia Market Share by Country (2020-2031)
Figure 23. United States Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nocturia Market Share by Country (2020-2031)
Figure 27. Germany Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nocturia Market Share by Region (2020-2031)
Figure 35. China Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nocturia Market Share by Country (2020-2031)
Figure 43. Mexico Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nocturia Market Share by Country (2020-2031)
Figure 47. Turkey Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Astellas Pharma Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 51. Allergan Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 52. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 55. Sanofi Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 58. Teva Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 59. Mylan Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 60. Novartis Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 61. Johnson & Johnson Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 63. Astra Zeneca Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 65. Hainan Zhonghe Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 66. Fosun Pharma Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 67. Hybio Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 68. Rechon Life Science AB Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 69. Zhejiang Conba Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 70. Chengdu Leer Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 71. Nanjing Xingyin Pharmaceutical Group Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 72. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 73. APOTEX INC Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 74. Sagent Pharmaceuticals Revenue Growth Rate in Nocturia Business (2020-2025)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
